COMMUNIQUÉS West-GlobeNewswire

First Line of Yoga-Centric Supplements Launches in Canada

22/01/2019 - 15:00

Toronto-based entrepreneur introduces Niyama™ Yoga Wellness to support the yoga lifestyle TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- The practice of yoga gives its students many benefits – from a calmer mind, to a [...]

Naboso™ Technology Expands Product Line to include the First Commercially Available Textured Insoles and Mats designed to Improve Posture, Balance and Strength through Stimulation of the Feet

22/01/2019 - 15:00

Patent-pending texture used in Naboso™ insoles and mats stimulates the nervous system through skin on the bottom of the feet, helping to benefit professional athletes and those with chronic neurological disorders like [...]

Editas Medicine Announces Chief Executive Officer Transition

22/01/2019 - 15:00

Katrine Bosley to Step Down as President and CEO Director Cynthia Collins to Serve as Interim CEO Board of Directors Initiates Search for Permanent Successor CAMBRIDGE, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Editas [...]

CV Sciences, Inc. Announces the Retirement of Its Founder and Management Restructure

22/01/2019 - 14:45

LAS VEGAS, Jan. 22, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that Michael Mona, Jr., the Company’s Founder and former President and Chief [...]

BrainStorm Granted Additional Patent for NurOwn® in Israel

22/01/2019 - 14:40

NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for debilitating neurodegenerative diseases, today announced [...]

Yield10 Bioscience Initiates Early Development Program in Corn to Evaluate Novel Traits

22/01/2019 - 14:30

WOBURN, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, [...]

TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma

22/01/2019 - 14:30

Three Confirmed Partial Responses (20%) by RECIST and > 50% Reductions of Alpha Fetoprotein in Half of Patients Treated to Date with Combination of TRC105 and Nexavar® Data Presented at ASCO 2019 Gastrointestinal [...]

Producing Supreme Cannabis At Scale -- CFN Media

22/01/2019 - 14:30

SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Albireo Granted Orphan Drug Designation by FDA For Lead Product Candidate A4250 for Treatment of Biliary Atresia

22/01/2019 - 14:30

Expands A4250 development potential in rare cholestatic liver diseases Biliary atresia is among the most common rare pediatric liver diseases and is the most common pediatric liver disease for which transplants are done [...]

CFN Media's Exclusive Interview with Aleafia Health CEO Geoffrey Benic Discussing Emblem Corp. Acquisition

22/01/2019 - 14:30

SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

World’s First Cannabis Validation Testing Program Hits the Market -- CFN Media

22/01/2019 - 14:30

SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Ultragenyx Announces Positive Topline Data from Ongoing Long-Term Extension Study of UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders

22/01/2019 - 14:30

Reductions in Major Clinical Events Sustained After an Additional 78 Weeks of UX007 Treatment Additional 20 Patients Naïve to UX007 Also Demonstrated Meaningful Reductions in Major Clinical Events with Treatment Company [...]

Advantis Corp. Set for Major Expansion in 2019

22/01/2019 - 14:30

Newport Beach, CA, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADVANTIS CORPORATION (OTC PINK: ADVT) CEO, Darren Cherry, recently took a moment to reflect on Advantis’ 2018 progress, and provided a look ahead [...]

Biome Secures Purchase Order with NSLC & Delivers First Shipment-- CFN Media

22/01/2019 - 14:30

SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Innovation Pharmaceuticals Announces Clinical Development Plans for Oral Brilacidin for Inflammatory Bowel Disease

22/01/2019 - 14:30

BEVERLY, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, is pleased to announce plans to initiate in 2019 a clinical trial of [...]

fMRI Data from Clinical Trial Demonstrate a Proposed Mechanism of Action for the Efficacy of Vayarin® Plus in Adults with ADHD

22/01/2019 - 14:20

Study Abstract Presented at the 2019 APSARD Annual Meeting in Washington, DC COLUMBIA, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. ( VAYA™ ), a division of Frutarom, Inc, and leader in developing specialty [...]

Allscripts to release fourth-quarter and full-year 2018 financial results February 21

22/01/2019 - 14:01

CHICAGO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months and full year ended December 31, 2018, after the close of stock [...]

Allscripts offers free pharmacogenomics testing to U.S.-based associates

22/01/2019 - 14:01

Program will help individuals understand the efficacy and safety of specific medications CHICAGO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions (NASDAQ: MDRX) today launched a precision medicine [...]

HempAmericana Commences Full-Scale Production with Significant Purchase Order for CBD Distillate

22/01/2019 - 14:00

NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is pleased to announce a significant Purchase Order for CBD Distillate from a major [...]